All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is ...

The boss of AstraZeneca said Europe should increase spending on health treatment in line with recent commitments on defence.

We recently published a list of 10 Most Undervalued Growth Stocks to Buy Now. In this article, we are going to take a look at ...

Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's a portfolio of dividend shares that could produce £115 of monthly passive income for investors who maximise their ISA ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...